Idazoxan (INN) is a drug which is used in scientific research. It acts as both a selective α2 adrenergic receptor antagonist and an antagonist for the imidazoline receptor. Idazoxan has been under investigation as an antidepressant but it did not reach the market as such. More recently it is under investigation as an adjunctive treatment in schizophrenia.
This page contains content from the copyrighted Wikipedia article "Idazoxan"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
